Performance Assessement for Paralympic Athletes

NCT04748497 | Unknown

• 2 other identifiers: APHP2011392020-A02919-30
• Study Type: interventional
• Target: 134
• Locations: 1 country
• Sites: 1

Brief Summary

The primary objective of the study: improvement of sportive performances by quantification and performances monitoring of paralympic athletes. The secondary objectives of the study:

• quantification and performances monitoring of mechanical performances during the filed tests, the laboratory analysis and the sportive competitions;
• quantification and performances monitoring of physiological performances during the filed tests, the laboratory analysis and the sportive competitions;
• quantification and risk monitoring of discipline-relative musculo-squeletic troubles, caused by training or using of sportive equipment;
• quantification and mechanical monitoring by the made-to-measure or usual sportive material.

Conditions

Paralympic Athletes; Sportive Performance

Keywords

paralympic athletes; performance

Outcome Measures

Primary Outcomes (4)

• Dynamic sportive activity

  Dynamic sportive activity: Sprint Capacity Test will be used to have maximal speed.

  through study completion, an average of 1 year

• Dynamic sportive activity

  Dynamic sportive activity: Sprint Capacity Test will be used to have maximal speed.

  at 42 months

• Static sportive activity

  Static sportive activity: maximal speed of movement of pression center.

  through study completion, an average of 1 year

• Static sportive activity

  Static sportive activity: maximal speed of movement of pression center.

  at 42 months

Secondary Outcomes (14)

• Biomechanical indices of performance: isometric power measurement

  through study completion, an average of 1 year

• Biomechanical indices of performance: arms and shoulder's Strength

  through study completion, an average of 1 year

• Physiological indices of performance: maximal aerobic speed (MAS)

  Twice through study completion, an average of 42 months

• Physiological indices of performance: maximal aerobic power

  Twice through study completion, an average of 42 months

• Fatigue assessment

  Twice through study completion, an average of 42 months

Study Arms (1)

Parasportives of various disciplines

OTHER

Other: Standardization of evaluation and follow-up

Interventions

Standardization of evaluation and follow-up OTHER

Standardization of evaluation and clinical and sportive follow-up of athletes. Made-to-measure technical supports will be tested regarding the Paralympic regulations.

Parasportives of various disciplines

Eligibility Criteria

• Age: 14 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• High-lever paralympic athletes registered on the ministerial list or selected by Parasport Federation of France or Shooting Federation of France;
• Aged \>= 14 years;
• Informed consent signed by adult athlete or by holder of parental authority or guardian for minor athlete;
• Covered by social security system.

You may not qualify if:

• Temporary or definitive contraindication to the practice of the affected sport activity;
• Undergoing anti-coagulated treatments;
• Cognitive disabilities conducting impossibility to participating to clinical trial, such as serious cognitive troubles, behaviors troubles, psychic troubles or upgraded curatorship needing;
• Under guardianship or judicial decision;
• Ongoing pregnancy.

Sponsors & Collaborators

• Assistance Publique - Hôpitaux de Paris: lead

Study Sites (1)

Service Médecine Physique et de Réadaptation, Hôpital Raymond Poincaré, APHP

Garches, 92380, France

RECRUITING

Study Officials

• François Genêt, MD, PhD

  Service Médecine Physique et de Réadaptation, Hôpital Raymond Poincaré, APHP

  PRINCIPAL INVESTIGATOR

• Jean François Toussaint, MD, PhD

  Centre d'Investigation en Médecine du Sport, Hôpital Hôtel Dieu, APHP

  STUDY DIRECTOR

Central Study Contacts

Jean François Toussaint, MD, PhD

CONTACT

+33 (0)1 42 34 82 10; jean-francois.toussaint@aphp.fr

François Genêt, MD, PhD

CONTACT

+33 (0)1.47.10.70.68; francois.genet@aphp.fr

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 11, 2020
• First Posted: February 10, 2021
• Study Start: January 8, 2021
• Primary Completion: June 1, 2024
• Study Completion: June 1, 2024
• Last Updated: March 22, 2022

Record last verified: 2022-03

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)